NINDS is committed to funding research that, by improving our understanding of how the brain and nervous system works, reduces the burden of neurological disorders and injuries.
Director's Messages
Displaying 61 - 67 of 67
Clinician-scientists, who understand diseases and disorders intimately due to their clinical training and practice, are critical to accomplishing the NINDS mission.
In addition to creativity, hard work and persistence, scientific discovery relies on researchers’ support to pursue critically important but difficult questions. This frequently requires long-term approaches and the ability to redirect experimental approaches as the evolving science dictates.
In a wonderful opportunity to look ahead and steer the course and field of neuroscience research, I am happy to announce the new 2021-2026 NINDS Strategic Plan: Investing in the Future. We are compelled to conduct this exercise every five years as we take stock of our progress and update the strategic plan to reflect our core values, our stakeholder’s needs, and the best ways to go about achieving our mission.
May is Stroke Awareness Month, an opportunity to remember that despite amazing advances in research and clinical care, stroke continues to be the fifth leading cause of death and a leading cause of adult disability in the United States. According to the 2018 National Health Interview Survey, 7.8 million adults in the United States have experienced a stroke during their lifetime.
Every day we are learning more about the effects of SARS-CoV-2 infection on the nervous system—in some cases detrimental effects that last far longer than the infection.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and severe disease that, according to the CDC, affects up to 2.5 million Americans, many of whom have not been diagnosed. Active NINDS efforts are underway to seek a better understanding of ME/CFS in order to treat—and ultimately prevent—this disease.